v3.26.1
Discontinued Operations - Summary of Discontinued Operations in Consolidated Statements of Income (Detail)
12 Months Ended
Dec. 31, 2024
USD ($)
Other income (expense):  
Discontinued operations, net $ 1,434,479
AxoBio [Member]  
Operating expenses:  
Research and development 89,972
General and administrative 470,686
Depreciation and amortization 636,449
Total operating expenses 1,197,107
Loss from operations (1,197,107)
Other income (expense):  
Amortization of debt discount (4,242)
Total other (expense) income (111,261)
Loss before income taxes (1,308,368)
Income tax benefit, deferred 156,092
Discontinued operations, net $ (1,152,276)
Discontinued Operation, Gain (Loss) on Disposal, Statement of Income or Comprehensive Income [Extensible Enumeration] Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
Related Party [Member] | AxoBio [Member]  
Other income (expense):  
Interest expense $ (89,448)
Nonrelated Party [Member] | AxoBio [Member]  
Other income (expense):  
Interest expense $ (17,571)